← Open Payments lookup

NKECHI ONWUCHE: Open Payments

NPI 1326409988 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,789 in 83 payments from 10 companies in 2025. Trend: 2023 $416 · 2024 $1,215 · 2025 $1,789

Food & beverage: $1,734Education: $55
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.26$482
Lundbeck LLC16$334
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$250
Alkermes, Inc.10$198
Janssen Pharmaceuticals, Inc3$121
Otsuka America Pharmaceutical, Inc.5$120
Teva Pharmaceuticals USA, Inc.4$89
Neurocrine BioSciences, Inc.3$82
Vanda Pharmaceuticals Inc.2$68
ABBVIE INC.2$43

Products named: COBENFY, ABILIFY ASIMTUFII, CAPLYTA, ARISTADA, INVEGA SUSTENNA, INGREZZA, FANAPT, UZEDY.

Industry payments across DC — which companies pay providers there.